Literature DB >> 2588123

Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma.

C Marcocci1, F Pacini, R Elisei, E Schipani, C Ceccarelli, P Miccoli, M Arganini, A Pinchera.   

Abstract

Thirty (3.8%) of 780 patients with differentiated thyroid cancer seen between 1970 and 1987 had bone metastases. The primary tumor was follicular in 26 patients and papillary in four. Mean age at diagnosis was 61 years. The manifestation of bone metastases was the presenting symptom in 18 patients (60%). Treatment included total thyroidectomy, levothyroxine sodium therapy, and radioactive iodine treatments. Twenty-seven patients had bone metastases from the initial observation, with 44 sites involved. Of the sites, 27 (61%) were shown both on iodine 131 whole-body scan (WBS) and on x-ray film, 11 (25%) only on WBS, and six (14%) only on x-ray film. Multiple involvement was observed in 11 patients. The radiologic appearance was invariably osteolytic. Serum thyroglobulin was elevated in all patients. After radioactive iodine, no WBS+/X-ray+ metastases showed a complete response, although a sclerotic border was noted in several cases, whereas six WBS+/X-ray- lesions were no longer detectable by WBS. Treatment with radioactive iodine and bone surgery resulted in a complete cure in three patients and in a reduction of tumor mass in three. Twenty-one (70%) of the patients died of thyroid cancer after a mean survival of 86 months. Of the nine patients still alive, two are free of disease, three have a good quality of life, and four have severe disability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2588123

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  26 in total

Review 1.  Recurrent or persistent thyroid cancer of follicular cell origin.

Authors:  M Duren; Q Y Duh; A E Siperstein; O H Clark
Journal:  Curr Treat Options Oncol       Date:  2000-10

2.  Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan.

Authors:  C Ceccarelli; F Bianchi; D Trippi; F Brozzi; F Di Martino; P Santini; R Elisei; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

3.  Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.

Authors:  Carlos A Benbassat; Sara Mechlis-Frish; Dania Hirsch
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

4.  Long-Term Outcome of Follicular Thyroid Carcinoma in Patients Undergoing Surgical Intervention for Skeletal Metastases.

Authors:  Anjali Mishra; Chitresh Kumar; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

5.  Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.

Authors:  F Tenenbaum; M Schlumberger; F Bonnin; J Lumbroso; B Aubert; H Benali; C Parmentier
Journal:  Eur J Nucl Med       Date:  1993-12

6.  Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?

Authors:  Elif Hindié; Didier Mellière; Françoise Lange; Iyad Hallaj; Claire de Labriolle-Vaylet; Christian Jeanguillaume; Jacques Lange; Léon Perlemuter; Serge Askienazy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

7.  Chest wall resection and reconstruction using titanium micromesh covered with Marlex mesh for metastatic follicular thyroid carcinoma: a case report.

Authors:  Nobuyasu Suganuma; Nobuyuki Wada; Hiromasa Arai; Hirotaka Nakayama; Keita Fujii; Katsuhiko Masudo; Norio Yukawa; Yasushi Rino; Munetaka Masuda; Toshio Imada
Journal:  J Med Case Rep       Date:  2009-06-08

8.  Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.

Authors:  G Mazziotti; A M Formenti; M B Panarotto; E Arvat; A Chiti; A Cuocolo; M E Dottorini; C Durante; L Agate; S Filetti; F Felicetti; A Filice; L Pace; T Pellegrino; M Rodari; M Salvatori; C Tranfaglia; A Versari; D Viola; S Frara; A Berruti; A Giustina; R Giubbini
Journal:  Endocrine       Date:  2017-11-06       Impact factor: 3.633

9.  Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?

Authors:  C A Proye; D H Dromer; B M Carnaille; A J Gontier; A Goropoulos; P Carpentier; J Lefebvre; M Decoulx; J L Wemeau; P Fossati
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

10.  Metastatic thyroid carcinoma of the adrenal gland.

Authors:  M E Girelli; D Casara; D Rubello; M Piccolo; A Piotto; M R Pelizzo; B Busnardo
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.